Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04164563 · ClinicalTrials.gov registry record · NA
Even-Up to Minimize Secondary Site Pain For Ankle Fracture
A NA study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04164563 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 6 participants.
The verdict
NCT04164563, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Evaluating impact of use of Even-Up shoe wear device for patients treated in CAM boot walker for an ankle fracture. Randomized controlled trial, randomizing patients into control group with boot treatment only versus boot treatment with Even-Up device on contralateral extremity.
Interventions
- DEVICE Even-Up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-11-14 |
| Est. Completion | 2020-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04164563
The ClinicalTrials.gov registry entry for NCT04164563 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Even-Up is the first listed.
NCT04164563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04164563 about?
NCT04164563 is a clinical study titled "Even-Up to Minimize Secondary Site Pain For Ankle Fracture". Evaluating impact of use of Even-Up shoe wear device for patients treated in CAM boot walker for an ankle fracture. Randomized controlled trial, randomizing patients into control group with boot treatment only versus boot treatment with Even-Up device on contralateral extremity.
What is the current status of trial NCT04164563?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2019-11-14. Estimated completion is 2020-09-10.
What interventions are being tested in trial NCT04164563?
The interventions under investigation include: Even-Up (DEVICE).
Who is sponsoring clinical trial NCT04164563?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.